No profile data available.
Precipio, Inc. (PRPO) is a healthcare company in the medical testing laboratories industry, based in New Haven, United States, with about 61 full-time employees.
It reported revenue of $24.05 million for fiscal year 2025, up 29.8% from fiscal year 2024, and net income of -$363,000. In Q2 2026 (the quarter ended June 30, 2026) revenue was $7.02 million, up 24.2% from a year before. Its market capitalization was $41.39 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Precipio reported $24.05 million in revenue for fiscal year 2025, up 29.8% from $18.53 million in fiscal year 2024. In Q2 2026 revenue was $7.02 million.
$41.39 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medical testing laboratories) include Biodesix, Inc. (BDSX), Prenetics Global Limited (PRE), Lucid Diagnostics Inc. (LUCD), Interpace Biosciences, Inc. (IDXG).